|
The
COVID-19 outbreak, which has upended the U.S. economy and so far
killed about 649,299 people in the country, has drawn renewed
attention to healthcare costs.
In August, President Biden said U.S. prescription drug costs
were two to three times higher than other nations in the world,
while urging lawmakers to enact legislation to lower drug
prices.
The U.S. Medicare program is a health insurance program for
people aged 65 and above, and those with disabilities.
The plan, to be released later on Thursday, will back
legislation aimed at lowering drug prices put forth by
congressional Democrats, the WSJ report said.
It will also outline other administrative measures such as
testing reimbursement for drugs in Medicare based on the
clinical value they provide to patients and federal funding for
research into new treatments, the report said.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini
Ganguli)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
